Host Cell Contaminant Testing Market : size is expected to reach US$ 3630.9 Mn. by year 2029 at a CAGR of 3.6% during the forecast period.

Host Cell Contaminant Testing Market Overview:

Host cell contaminants are generally the host cell proteins (HCPs), Host Cell Contaminant Testing Market which are the impurities found in biotechnological products that can cause immunogenicity and reduce the potency or stability of a drug and risk the patient safety. Currently, the acceptable level of HCPs in pharmaceutical drugs range from 1-100ppm (1–100 ng/mg product). These products require protein recovery processes to minimize their content in a final product. They are also often immunogenic and pose risks to both the efficacy of a drug and patient safety

Request for free sample : https://www.maximizemarketresearch.com/request-sample/88498

Market Scope:

The host cell contaminant testing market will expand as a result of ongoing testing-related R&D efforts and an increase in the number of regulatory approvals for testing tools. The market is also anticipated to increase as a result of other reasons including rising demand for personalized medications and rising occurrences of chronic diseases like cancer, which call for novel, advanced biopharmaceutical products. The International Agency for Research on Cancer reported that in 2018, there were 18.1 million new cases of cancer. The commercial expansion, however, may be hampered by immunogenic reactions, expensive testing costs, and technological challenges related to host cell proteins. In June 2022, Cygnus Technologies announced that it would be increasing the services it offers for the identification of host cell protein (HCP) contaminants.

Segmentation:

by Type :

• Microbial

• Mammalian

Based on the HPV drug class, the Host Cell Contaminant Testing Market has been segmented into Immunomodulators, Keratolytic agents, Anti-neoplastic agents and Sinecatechins. Immunomodulators segment account for the largest share of the HPV therapeutics market in 2018. The Sinecatechins segment is expected to grow at the largest CAGR of xx% during the forecast period.

by Test :

• PCR based assays

• ELISA based assays

Based on the application, the genital warts segment held the dominant market share in terms of revenue generation, due to higher number of HPV strains leading to genital warts which are easily transmitted through sexual contact. Genital warts soft progresses that act on the genitals, Genital warts can cause lots of pain, discomfort, and itching. Increasing demand for minimally invasive surgical procedures in genital warts treatment will drive the market growth. Dry therapeutic pipeline and serious threat from substitutes such as Cryotherapy and laser therapy have made the market less attractive.

by End Users :

• Pharmaceutical & Biotechnology Industries

• Research & Academic Institutes

• Diagnostics Centers

• Others

ELISA (Enzyme-Linked Immunosorbent Assay) is the predominantly used process for the detection of Host Cell Contamination, owing to its high sensitivity to proteins that detects the low level of HCPs produced in drugs, high level of reproducibility and compatibility with high-throughput screening. Despite these factors, there are also several limitations associated with the procedure. Thermo Fisher Scientific announced the launch of a new product for the host cell contaminant testing in November 2022. The company introduced ‘Torrent Genexus System,’ a product that is described as the first fully integrated next-gen sequencing platform, which includes an automated specimen-to-report workflow that is capable of delivering efficient results in a single day.

Host Cell Contaminant Testing Market : Research Methodology


Host Cell Contaminant Testing Market : Executive Summary
Market Overview and Definitions
Introduction to Host Cell Contaminant Testing Market
Summary
Key Findings
Recommendations for Investors
Recommendations for Market Leaders
Recommendations for New Market Entry


Host Cell Contaminant Testing Market : Competitive Analysis
MMR Competition Matrix
Market Structure by region
Competitive Benchmarking of Key Players
Consolidation in the Market
M&A by region
Key Developments by Companies
Market Drivers
Market Restraints
Market Opportunities
Market Challenges
Market Dynamics
PORTERS Five Forces Analysis
PESTLE
Regulatory Landscape by region
North America
Europe
Asia Pacific
Middle East and Africa
South America
COVID-19 Impact


Host Cell Contaminant Testing Market Segmentation
Host Cell Contaminant Testing Market , by Type (2021-2029)
Host Cell Contaminant Testing Market , by Test (2021-2029)
Host Cell Contaminant Testing Market , by End Users (2021-2029)


Regional Host Cell Contaminant Testing Market (2021-2029)
Regional Host Cell Contaminant Testing Market , by Type (2021-2029)
Regional Host Cell Contaminant Testing Market , by Test (2021-2029)
Regional Host Cell Contaminant Testing Market , by End Users (2021-2029)
Regional Host Cell Contaminant Testing Market , by Country (2021-2029)


Company Profile: Key players
Company Overview
Financial Overview
Global Presence
Capacity Portfolio
Business Strategy
Recent Developments


Key Players:

• BioGenes GmbH

• Bio-Rad Laboratories, Inc.

• Cisbio Bioassays

• Cygnus Technologies LLC (A Maravai Lifesciences Company)

• Enzo Life Sciences, Inc.

• ForteBio (A Pall Company)

• GE Healthcare Life Sciences

• Molecular Devices LLC

• ProteinSimple (A BioTechne Brand)

• Thermo Fisher Scientific, Inc.

• BioAgilyTix labs

• BioTechne

• Others

Request for free sample : https://www.maximizemarketresearch.com/request-sample/88498

Regional Analysis:

Owing to the increased expenditure for research and development activities and ongoing developments in the biopharmaceutical industries for the development of novel techniques for reducing host cell contamination in many research and academic institutes are driving the market growth in the region. Also, the improving healthcare infrastructures, coupled with the rising healthcare budgets in the United States will propel the growth of the market in North America.

COVID-19 Impact Analysis on Host Cell Contaminant Testing Market : The COVID-19 pandemic has had significant implications for various sectors of the economy worldwide, including the transportation and logistics industry. The tank container market, which involves the transportation of bulk liquids and gases, has also been affected by the pandemic in India.

Key Questions Answered in the Host Cell Contaminant Testing Market Report are:

1. Which region has the largest share in Global Host Cell Contaminant Testing Market ?
Ans: Europe region held the highest share in 2022.
2. What is the growth rate of Global Host Cell Contaminant Testing Market ?
Ans: The Global Host Cell Contaminant Testing Market is growing at a CAGR of 7% during forecasting period 2023-2029.
3. What is scope of the Global Host Cell Contaminant Testing Market report?
Ans: Global Host Cell Contaminant Testing Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global Host Cell Contaminant Testing Market ?
Ans: The important key players in the Global Host Cell Contaminant Testing Market are – Therapure Biopharma Inc.,Sanguine Biosciences,Northfield Laboratories Inc.,Baxter Healthcare Corp.,Alliance Pharmaceutical,FLUORO2 Therapeutics,Alpha Therapeutic Corp.,Kalocyte,Hemarina,Green Cross Corp.,Biopure Corp,Sangart Corporation
5. What is the study period of this Market?
Ans: The Global Host Cell Contaminant Testing Market is studied from 2022 to 2029.

About Us
Maximize Market Research provides B2B and B2C research on 6,500 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.



Contact US



MAXIMIZE MARKET RESEARCH PVT. LTD.
⮝ 3rd Floor, Navale IT Park Phase 2,
Pune Bangalore Highway,
Narhe,
Pune, Maharashtra 411041, India.